Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1976-8-2
|
pubmed:abstractText |
Among 1242 patients referred for immunologic investigation 1255 M components were detected in the serum. Of these patients 50.9% had multiple myeloma, 18.1% had nonmyelomatous malignant diseases such as macroglobulinemia, lymphoma, leukemia or cancer, 4.3% had connective tissue diseases, 2.5% had primary generalized amyloidosis (PGA) and the rest had various "benign" conditions. Whereas IgG was the commonest M component in multiple myeloma, connective tissue diseases and the other benign conditions, IgM was the commonest M component in lymphoma and leukemia; Bence Jones proteinemia was most frequently observed in PGA. The ratio of kappa to lambda light chains varied from 1.7:1 in IgG myeloma to 1:9 in IgD myeloma, and was 1:2.1 in PGA. Bence Jones protein was detected in 422 (66%) of 640 urine samples tested, the prevalence ranging from more than 70% in multiple myeloma and PGA to as low as 36% in various benign conditions. It is evident that the class and type of M components and the presence of Bence Jones proteinuria have no definite significance with regard to the diagnosis. Therefore, thorough investigation and follow-up at regular intervals are required when M components are detected.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/817789-4118149,
http://linkedlifedata.com/resource/pubmed/commentcorrection/817789-4160039,
http://linkedlifedata.com/resource/pubmed/commentcorrection/817789-4160527,
http://linkedlifedata.com/resource/pubmed/commentcorrection/817789-4216192,
http://linkedlifedata.com/resource/pubmed/commentcorrection/817789-4544079,
http://linkedlifedata.com/resource/pubmed/commentcorrection/817789-4964131,
http://linkedlifedata.com/resource/pubmed/commentcorrection/817789-5003017,
http://linkedlifedata.com/resource/pubmed/commentcorrection/817789-807730
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-4409
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
114
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
889-92, 895
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:817789-Adult,
pubmed-meshheading:817789-Amyloidosis,
pubmed-meshheading:817789-Bence Jones Protein,
pubmed-meshheading:817789-Connective Tissue,
pubmed-meshheading:817789-Humans,
pubmed-meshheading:817789-Immunoglobulins,
pubmed-meshheading:817789-Leukemia,
pubmed-meshheading:817789-Lymphoma,
pubmed-meshheading:817789-Waldenstrom Macroglobulinemia
|
pubmed:year |
1976
|
pubmed:articleTitle |
M components-a review of 1242 cases.
|
pubmed:publicationType |
Journal Article
|